| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/17/2008 | CN101326180A Piperazine derivative renin inhibitors |
| 12/17/2008 | CN101326179A New pyrimidine derivatives and their use in therapy as well as the use of pyrimidine derivatives in the manufacture of a medicament for prevention and/or treatment of alzheimer's disease |
| 12/17/2008 | CN101326178A Piperazine derivatives useful as CCR5 antagonists |
| 12/17/2008 | CN101326177A Dihydroisoindolones as allosteric modulators of glucokinase |
| 12/17/2008 | CN101326175A Polymorphs of a C-MET/HGFR inhibitor |
| 12/17/2008 | CN101326173A Thiadiazoles derivant as anti-diabetes agent |
| 12/17/2008 | CN101326172A Improved jasmonate derivatives, pharmaceutical compositions and methods of use thereof |
| 12/17/2008 | CN101326171A Novel dual peptidase inhibitors as prodrugs for the therapy of inflammatory and other disorders |
| 12/17/2008 | CN101326170A Novel macrolide compounds with antibiotic and antneoplastic properties |
| 12/17/2008 | CN101326169A Glucocorticoid receptor modulators as antiinflammatory agents |
| 12/17/2008 | CN101326168A Prokineticin 1 receptor antagonists |
| 12/17/2008 | CN101326167A Pyridiazinone derivatives for tumour treatment |
| 12/17/2008 | CN101326166A Novel N-sulfamoyl-piperidineamides for the prophylaxis or treatment of obesity and related conditions |
| 12/17/2008 | CN101326164A Inhibitors of CCR9 activity |
| 12/17/2008 | CN101326163A Prolinamide derivatives as sodium channel modulators |
| 12/17/2008 | CN101326162A Quaternary alpha-aminocarboxamide derivatives as modulators of voltage-gated sodium channels |
| 12/17/2008 | CN101326160A Biphenyloxyacetic acid derivatives for the treatment of respiratory disease |
| 12/17/2008 | CN101326157A Diphenyl urea derivatives |
| 12/17/2008 | CN101326156A Diphenyl urea derivatives |
| 12/17/2008 | CN101326155A Propionamide compounds as antiinflammatory agents |
| 12/17/2008 | CN101325973A Use of oligouronates for treating mucus hyperviscosity |
| 12/17/2008 | CN101325959A Combination therapy for controlled carbohydrate digestion |
| 12/17/2008 | CN101325958A Crystalline lestaurtinib hydrates and crystalline lestaurtinib hemihydrate hemiacetonitrileate and crystalline lestaurtinib hemihydrate hemitetrahydrofuranate |
| 12/17/2008 | CN101325957A Microangiopathy treatment and prevention |
| 12/17/2008 | CN101325956A Compounds for the treatment of auricular fibrillation |
| 12/17/2008 | CN101325955A Method of treating cancers with saha and pemetrexed |
| 12/17/2008 | CN101325954A Quinazolinone derivatives as vanilloid antagonists |
| 12/17/2008 | CN101325953A 4-heteroaryl-pyrimidine derivatives and use thereof as protein kinase inhibitors |
| 12/17/2008 | CN101325952A Agent for prevention and treatment of acute renal failure |
| 12/17/2008 | CN101325951A Leucine rich composition |
| 12/17/2008 | CN101325950A Methods of treating central nervous system disorders with a low dose combination of escitalopram and bupropion |
| 12/17/2008 | CN101325882A Nutritional supplement containing long-chain polyunsaturated fatty acids |
| 12/17/2008 | CN101325874A Trioxane dimers having high anticancer and long-lasting antimalarial activities |
| 12/17/2008 | CN101325871A Use of low-dose Ladostigil for neuroprotection |
| 12/17/2008 | CN101323873A Ginseng polysaccharide extraction process |
| 12/17/2008 | CN101323649A Method for extracting mushroom polysaccharide by using ultra-high pressure |
| 12/17/2008 | CN101323646A Phellinus polysaccharide II having antineoplastic activity, extraction and separation method thereof |
| 12/17/2008 | CN101323635A Panax notoginseng saponins ST-4, and medicinal composition, preparation and use thereof |
| 12/17/2008 | CN101323634A Induced nuclear receptor TR3 expressed cardiac glycoside compounds and use thereof |
| 12/17/2008 | CN101323631A Phosphine transition-metal coordination compound having ferrocene frame having ferrocene frame, manufacturing method thereof and carcinostatic agent |
| 12/17/2008 | CN101323629A 4-{6-[5-(2-chlorinde-6- methylaniline formyl)-thiazole-2-amido]-2-methyl pyrimidine-4}-piperazine-1- diethyl methylphosphate |
| 12/17/2008 | CN101323623A Novel fourth generation cephalosporin, preparation and use thereof |
| 12/17/2008 | CN101323616A Carbpenem derivates containing sulfhydryl thiazole |
| 12/17/2008 | CN101323615A Pennem derivates containing formamide heterocycle sulfonic acid amide sulfhydryl pyrrolidine |
| 12/17/2008 | CN101323613A Berberine additive product, medicament containing the same and preparation thereof |
| 12/17/2008 | CN101323606A Extraction and purification method of sesquiterpenes coumarin ether and use thereof |
| 12/17/2008 | CN101323604A Novel PPAR alpha/beta dual agonist, preparation and use thereof |
| 12/17/2008 | CN101323601A Triazole derivatives useful in therapy |
| 12/17/2008 | CN101323600A Triadimefon and triadimenol compounds having antimicrobial activity, salts, synthetic methods and uses thereof |
| 12/17/2008 | CN101323594A Benzyl chloride tertiary amine double azole antimicrobial compounds, preparation and medical use thereof |
| 12/17/2008 | CN101323591A 5- or 6-substited naphthoyl imines compounds and antineoplastic application |
| 12/17/2008 | CN101322848A Composition for gastroscopy and preparation thereof |
| 12/17/2008 | CN101322846A Compositions containing inclusion complexes |
| 12/17/2008 | CN101322845A Erianin inclusion compound |
| 12/17/2008 | CN101322833A Sedative and brain-invigorating oral liquid with improved clarity and stability and preparation thereof |
| 12/17/2008 | CN101322827A Chinese medicinal composition for treating chronic atrophic gastritis and preparation thereof |
| 12/17/2008 | CN101322819A Agent for treating tinea manus and pedis and onychomycosis |
| 12/17/2008 | CN101322809A Ultra-high biomass high activity Chinese medicine preparation series for regenerating biological reaction, activating blood circulation and resolving stasis |
| 12/17/2008 | CN101322808A Bone fracture setting ointment |
| 12/17/2008 | CN101322807A Paster for long life acupuncture point on foot bottom |
| 12/17/2008 | CN101322805A Plaster for activating blood, resolving stasis, dispelling arthralgia spasm and easing pain, and preparation |
| 12/17/2008 | CN101322796A Pain-easing plaster for protrusion of lumbar vertebral disc |
| 12/17/2008 | CN101322791A Chinese medicine for treating chronic anemia |
| 12/17/2008 | CN101322786A External-use medicament for treating bone fracture and traumatic injury |
| 12/17/2008 | CN101322780A Formulation for delaying aging, improving cardiovascular and cerebrovascular condition, and prolonging life and preparation thereof |
| 12/17/2008 | CN101322770A Compound creat formulation for resisting infection |
| 12/17/2008 | CN101322768A Medical ointment for treating burn and scald |
| 12/17/2008 | CN101322764A External use medicament for treating hyperosteogeny of cervical vertebra and lumbar principally and preparation thereof |
| 12/17/2008 | CN101322762A Medicinal composition for treating diabetes |
| 12/17/2008 | CN101322747A Medicament for treating mammitis |
| 12/17/2008 | CN101322743A Formulation capable of repairing lesion and damnification of eye and improving asthenopia and preparation thereof |
| 12/17/2008 | CN101322742A Health care face-nursing formulation |
| 12/17/2008 | CN101322739A Prescription of Chinese medicine health care capsules mixed with nucleotide and aminoacid and preparing technique |
| 12/17/2008 | CN101322734A Codonopsis lanceolata total saponins with antiinflammatory immunity function and preparation thereof |
| 12/17/2008 | CN101322722A Compound carbamylcholine chloride injection for animals and preparation method thereof |
| 12/17/2008 | CN101322718A Injection for reducing drug dependency and preparation thereof |
| 12/17/2008 | CN101322717A Medicament composition for preventing and treating eye diseases |
| 12/17/2008 | CN101322716A Applications of anthocyanin and regulation for CHOP gene in preventing and treating atherosclerosis |
| 12/17/2008 | CN101322715A Anti-coxsackie medicament composition and medicine use thereof |
| 12/17/2008 | CN101322714A Anti-herpes simplex virus I-form medicament composition and uses thereof |
| 12/17/2008 | CN101322713A Applications of gastrodine in preparing cysteine proteinase-3 active inhibitor |
| 12/17/2008 | CN101322712A Alprostadil nano granule formulation and preparation thereof |
| 12/17/2008 | CN101322711A Health care medicament for resisting fatigue and enhancing immunity and preparation thereof |
| 12/17/2008 | CN101322710A Levosimendan emulsion for intravenous injection and preparation thereof |
| 12/17/2008 | CN101322709A Medicament composition containing aripiprazole and preparation thereof |
| 12/17/2008 | CN101322708A Extended release oral dosage composition |
| 12/17/2008 | CN101322707A Pharmaceutical composition containing histone deacetylase inhibitor |
| 12/17/2008 | CN101322706A Applications of hexa-gelsemicine in preparing medicament for treating chronic ache |
| 12/17/2008 | CN101322705A Applications of koumine in preparing medicament for treating chronic ache |
| 12/17/2008 | CN101322704A Applications of gelsemine in preparing medicament for treating chronic ache |
| 12/17/2008 | CN101322703A Granisetron hydrochloride mouth spray |
| 12/17/2008 | CN101322702A Piperacillin sodium and sulbactam sodium for injection and preparation of freeze-dried injection thereof |
| 12/17/2008 | CN101322701A Amoxicillin sodium and sulbactam sodium for injection and preparation of freeze-dried injection thereof |
| 12/17/2008 | CN101322700A Applications of naringenin and naringin as signal pathway inhibitor of transforming growth factor-beta 1 |
| 12/17/2008 | CN101322699A Preparation of docetaxel liposome and freeze-dried powder injection thereof |
| 12/17/2008 | CN101322698A Applications of betaine in preparing medicament for preventing and treating alimentary obesity |
| 12/17/2008 | CN101322695A Piclofenac potassium sustained release capsule and preparing technique thereof |
| 12/17/2008 | CN101322694A Piclofenac potassium sustained release tablets and preparing technique thereof |
| 12/17/2008 | CN101322693A Carthamus tinctorius yellow colour injection and preparation technique thereof |
| 12/17/2008 | CN101322692A Hydrochloric clindamycin nano granule formulation for injections and preparation thereof |